“Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial” (2019) Swiss Medical Weekly, 149(3940), p. w20132. doi:10.4414/smw.2019.20132.